The service aims at offering the possibility to evaluate the outcome of an infection by a SARS-CoV-2 strain or variant in a susceptible cell line : evaluation of the susceptibility of a cell line, evaluation of the infectivity of a variant compared to a reference variant, evaluation of the effect of infection on a cellular pathway etc... The project can be refined upon request
Freeze-dried SARS-CoV-2 virus, strain SARS-CoV-2/2021/FR/0610 (Lineage B 1.617.2, Delta) France 2021, complete genome sequence.
Presence of spike mutation A222V and absence of spike mutation Y145H.
Freeze-dried SARS-CoV-2 virus, strain UVE/SARS-CoV-2/2020/FR/702, France 2020, complete genome sequence.
NB: this virus contains the G614 european mutation in the spike sequence
Panel of Freeze-dried SARS-CoV-2 variants (Europe, UK, South Africa, Brazil, Delta).
Please note Brazilian variant can not be supplied to private entities
Freeze-dried SARS-CoV-2 virus, strain SARS-CoV-2/2021/JP/TY7-503 (lineage P.1, ex Brazil) Japan 2021, complete genome sequence.
Please note this product can not be supplied to private entities
Freeze-dried SARS-CoV-2 virus, strain SARS-CoV-2/2021/JP/TY7-501 (lineage P.1, ex Brazil) Japan 2021, complete genome sequence. Please note this product can not be supplied to private entities
Freeze-dried SARS-CoV-2 virus, isolate England/MIG457/2020 (lineage B.1.1.7), England 2020, complete genome.
Please note this product can not be supplied to private entities
Freeze dried SARS-CoV-2 virus, strain UVE/SARS-CoV2/2020/FR/ISA_D614 generated by ISA method. It contains the original D614 residue on the Spike protein